We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Releases Biosimilar Labeling Draft Guidance
Following months of pressure from industry, the FDA has released draft guidance on biosimilars labeling, recommending that sponsors incorporate into product labeling information from the reference product labeling.